ACERTA-CL-3111 is now open at Sir Charles Gairdner Hospital

This phase 3 study is for patients with untreated Chronic lymphocytic leukemia (CLL)

Chronic lymphocytic leukemia (also called CLL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). CLL is a blood and bone marrow disease that usually gets worse slowly. CLL is one of the most common types of leukemia in adults and it often occurs during or after middle age.

The study is being ran at Sir Charles Gairnder, with Dr Gavin Cull (below) as the Principal Investigator. For further information and contact details, visit our website: